NASUS PHARMA LTD

Q4 2025 13F Holders

Symbol
NSRX
CUSIP
M7071P109
Type
Equity
Class
ORD SHS
Num filings
2
Total reported value, excl. options
$21.8 k
Manager Report Date Value ($000) Shares Option Type